| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.04 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |